Combined Use of Broad-Spectrum Antibiotics in Phthisiology
Abstract
Aim. To investigate pharmacokinetic and pharmacodynamic interactions of levofloxacin, kanamycin and linezolid in combined chemotherapy of multidrug-resistant tuberculosis. Materials and Methods. We investigated pharmacological interactions between levofloxacin, kanamycin and linezolid using GalaxyWEB GalaxySagittarius – AlphaFold software. Results. We found that levofloxacin can interact through the carboxyl group (–COOH) with compounds containing an amino group, in particular with linezolid and kanamycin, in order to form a carbamide bond -CO-NH-. Levofloxacin is also able to form an azomethine bond via the carbonyl group –C = O with drugs containing the primary amino group (kanamycin and linezolid). 3D models of the drug compounds with plasma proteins were visualized and protein matches of paired intake of drugs were determined: Levofloxacin – Linezolid pair – 181 matches, Levofloxacin – Kanamycin pair – 11 matches, Kanamycin – Linezolid pair – 8 matches. After 1.5-2 hours after the intake of levofloxacin – linezolid - kanamycin, these drugs reached peak concentrations. Levofloxacin and linezolid were primarily metabolized in the liver and kanamycin has not been metabolized at all. All three drugs were excreted by the kidneys. Conclusion. The analysis demonstrated effectiveness of Galaxy Sagittarius – AlphaFold technology and found a significant level of drug-protein complexes. The interaction of linezolid, levofloxacin and kanamycin led to an increase in the effectiveness…
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.